Cardiology Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA.
Weill Cornell Medical College, New York, NY, USA.
Curr Treat Options Oncol. 2021 Jun 7;22(7):58. doi: 10.1007/s11864-021-00855-y.
Cardio-oncology is a field dedicated to the prevention, diagnosis, and management of cardiovascular disease in cancer patients before, during, and after cancer therapy. It is an emerging field with limited opportunities for structured education and training. In the year 2021, we cannot define the requirements of cardio-oncology training without acknowledging the impact of the global coronavirus disease 19 (COVID-19) pandemic. While this pandemic poses significant health risks to patients with cancer and cardiovascular disease as well as the providers who care for them, it also allows novel opportunities for the nascent field of cardio-oncology to readily adapt. In this article, we detail how the COVID-19 pandemic has impacted all aspects of cardio-oncology training, how programs and trainees can adapt to these challenges, and how lessons learned from the COVID-19 era can continue to positively impact cardio-oncology training for the foreseeable future.
肿瘤心脏病学是一个致力于在癌症治疗之前、期间和之后预防、诊断和管理癌症患者心血管疾病的领域。这是一个新兴的领域，结构化的教育和培训机会有限。在 2021 年，如果不承认全球冠状病毒病 19（COVID-19）大流行的影响，我们就无法定义肿瘤心脏病学培训的要求。虽然这场大流行给患有癌症和心血管疾病的患者以及为他们提供治疗的医护人员带来了巨大的健康风险，但它也为新兴的肿瘤心脏病学领域提供了很好的适应机会。在本文中，我们详细介绍了 COVID-19 大流行如何影响肿瘤心脏病学培训的各个方面，以及计划和学员如何适应这些挑战，以及从 COVID-19 时代吸取的经验教训如何继续为可预见的未来积极影响肿瘤心脏病学培训。
